Nota informativa de Sun Trust. Mantiene su PO a 6$
https://drive.google.com/file/d/0B1gB2YESBJV7SC1KajJVanlWWG8/view
Destaco lo que nos interesa:
Further deals in EU and LatAm anticipated .
We see the Eddingpharm deal as a likely precursor to additional partnerships in Eastern & Western European & Latin American markets that could be announced later this year. Amarin is ideally looking for a single partner in Europe, but also is considering separate arrangement for the major Western markets vs. Eastern Europe in parallel. We also expect AMRN to seek a partner for major LatAm markets such as Brazil & Mexico, though timelines are more difficult to anticipate relative to Europe. We believe that such future deals will have similar upfront payment, milestone, and royalty structures, reflected in our estimates and would provide further upside.
AMRN